Estimation of outpatient SARS-CoV-2 reinfection and recurrence rates and associated factors among COVID-19 hospitalized patients over one-year old: a multicenter retrospective cohort study

被引:1
|
作者
Mokhayeri, Yaser [1 ]
Taherpour, Niloufar [2 ]
Shahbazi, Fatemeh [3 ]
Ghorbani, Sahar Sotoodeh [4 ]
Fallah, Saeid [5 ]
Etemad, Koorosh [4 ]
Izadi, Neda [6 ]
Mehri, Ahmad [4 ]
Farhadi-Babadi, Kosar [4 ]
Rahimi, Elham [4 ]
Feyzi, Rezvan [4 ]
Seifi, Arash [7 ]
Nazari, Seyed Saeed Hashemi [8 ]
机构
[1] Lorestan Univ Med Sci, Shahid Rahimi Hosp, Cardiovasc Res Ctr, Khorramabad, Iran
[2] Shahid Beheshti Univ Med Sci, Prevent Cardiovasc Dis Res Ctr, Tehran, Iran
[3] Hamadan Univ Med Sci Hamadan, Sch Hlth, Dept Epidemiol, Hamadan, Iran
[4] Shahid Beheshti Univ Med Sci, Sch Publ Hlth & Safety, Dept Epidemiol, Tehran, Iran
[5] Golestan Univ Med Sci, Hlth Management & Social Dev Res Ctr, Gorgan, Iran
[6] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Res Ctr Social Determinants Hlth, Tehran, Iran
[7] Univ Tehran Med Sci, Fac Med, Dept Infect Dis, Tehran, Iran
[8] Shahid Beheshti Univ Med Sci, Prevent Cardiovasc Dis Res Ctr, Sch Publ Hlth & Safety, Dept Epidemiol, Daneshjoo Blvd,Evin Ave, Tehran 1983535511, Iran
关键词
SARS-Cov-2; Reinfection; Recurrence; Out-patient; Iran; RISK-FACTORS; INFECTION;
D O I
10.1186/s12879-024-09872-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
IntroductionReinfection with SARS-Cov-2 after recovery can occur that most of them don't require hospitalization. The aim of this study is estimation of out-patient COVID-19 reinfection and recurrence rates and its associated factors among Iranian patients with history of confirmed SARS-Cov-2 infection and hospitalization.MethodsThis study is a retrospective cohort conducted from May 2021 to May 2022 in Iran. The national Medical Care Monitoring Center (MCMC) database, obtained from the Ministry of Health and Medical Education, includes all information about confirmed COVID-19 patients who are hospitalized and diagnosed during the pandemic. Using probability proportional to size sampling from 31 provinces, 1,532 patients over one years of age with a history of hospitalization in the MCMC data are randomly selected. After that, interviews by phone are performed with all of the selected patients using a researcher-made questionnaire about the occurrence of overall reinfection without considering the time of infection occurrence, reinfection occurring at least 90 days after the discharge and recurrence (occurring within 90 days after discharge). Univariate and multivariable Cox regression analyses are performed to assess the factors associated with each index. All of the analyses are performed using Stata software version 16.ResultsIn general, 1,532 phone calls are made, out of which 1,095 individuals are willing to participate in the study (response rate similar or equal to 71%). After assessing the 1,095 patients with a positive history of COVID-19, the rates of non-hospitalized overall SARS-Cov-2 reinfection, reinfection and recurrence are 122.64, 114.09, and 8.55 per 1,000 person-years, respectively. The age range of 19-64 years (aHR:3.93, 95%CI : 1.24-12.41) and COVID-19-related healthcare worker (aHR: 3.67, 95%CI: 1.77-7.61) are identified as risk factors for reinfection, while having comorbidity, being fully vaccinated, and having a partial pressure of oxygen (PaO2) >= 93 mmHg during the initial infection are identified as factors that reduce the risk of non-hospitalized reinfection.ConclusionReinfection due to COVID-19 is possible because of the weakened immune system for various reasons and the mutation of the virus. Vaccination, timely boosters, and adherence to preventive measures can help mitigate this risk.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Covid-19 vaccination programme effectiveness against SARS-CoV-2 related infections, hospital admissions and deaths in the Apulia region of Italy: a one-year retrospective cohort study
    Tobias Homan
    Sara Mazzilli
    Antonio Chieti
    Alessandra Musa
    Adam Roth
    Francesca Fortunato
    Lucia Bisceglia
    Rosa Prato
    Pier Luigi Lopalco
    Domenico Martinelli
    Scientific Reports, 12
  • [22] Covid-19 vaccination programme effectiveness against SARS-CoV-2 related infections, hospital admissions and deaths in the Apulia region of Italy: a one-year retrospective cohort study
    Homan, Tobias
    Mazzilli, Sara
    Chieti, Antonio
    Musa, Alessandra
    Roth, Adam
    Fortunato, Francesca
    Bisceglia, Lucia
    Prato, Rosa
    Lopalco, Pier Luigi
    Martinelli, Domenico
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [23] Attributes and factors associated with long covid in patients hospitalized for acute COVID-19: A retrospective cohort study
    Minassie, Bethlehem Berhanu
    Degu, Wondwossen Amogne
    Etissa, Eyob Kebede
    Asfeha, Natnael Fitsum
    Alemayehu, Salem Taye
    Huluka, Dawit Kebede
    PLOS ONE, 2025, 20 (01):
  • [24] Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden
    Nordstrom, Peter
    Ballin, Marcel
    Nordstrom, Anna
    LANCET INFECTIOUS DISEASES, 2022, 22 (06): : 781 - 790
  • [25] SARS-CoV-2 and auto-antibodies in the cerebrospinal fluid of COVID-19 patients: prospective multicenter cohort study
    Nersesjan, V.
    Amiri, M.
    Nilsson, A.
    Wamberg, C.
    Storm, S.
    Jensen, V.
    Petersen, C.
    Hejl, A.
    Lebech, A.
    Theut, A.
    Jorgensen, C.
    Blaabjerg, M.
    Benros, M.
    Kondziella, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 296 - 297
  • [26] SARS-CoV-2 Genomic Characteristics and Clinical Impact of SARS-CoV-2 Viral Diversity in Critically Ill COVID-19 Patients: A Prospective Multicenter Cohort Study
    Fourati, Slim
    Audureau, Etienne
    Arrestier, Romain
    Marot, Stephane
    Dubois, Claire
    Voiriot, Guillaume
    Luyt, Charles-Edouard
    Urbina, Tomas
    Mayaux, Julien
    Roque-Afonso, Anne-Marie
    Pham, Tai
    Landraud, Luce
    Visseaux, Benoit
    Roux, Damien
    Bellaiche, Raphael
    L'honneur, Anne-Sophie
    Ait Hamou, Zakaria
    Brichler, Segolene
    Gaudry, Stephane
    Salmona, Maud
    Clere-Jehl, Raphael
    Azoulay, Elie
    Morand-Joubert, Laurence
    Marcelin, Anne-Genevieve
    Chaix, Marie-Laure
    Descamps, Diane
    Mekontso Dessap, Armand
    Rodriguez, Christophe
    Pawlotsky, Jean-Michel
    de Prost, Nicolas
    VIRUSES-BASEL, 2022, 14 (07):
  • [27] The persistence of SARS-CoV-2 neutralizing antibodies after COVID-19: A one-year observation. Is a SARS-CoV-2 vaccination booster dose necessary?
    Tworek, Adam
    Jaron, Krzysztof
    Cicha, Malgorzata
    Rydzewski, Andrzej
    Wierzba, Waldemar
    Zaczynski, Arturza
    Krol, Zbigniew
    Rydzewska, Grazyna
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 48 (02) : 92 - 96
  • [28] Factors associated with a SARS-CoV-2 recurrence after hospital discharge among patients with COVID-19: systematic review and meta-analysis
    Yao, Meng-qi
    Zheng, Qiu-xian
    Xu, Jia
    Deng, Jing-wen
    Ge, Tian-tian
    Zhou, Hai-bo
    Wu, Feng-tian
    Gu, Xin-yu
    Yang, Qin
    Ren, Yan-li
    Wang, Gang
    Chen, Zhi
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2020, 21 (12): : 940 - 947
  • [29] Mortality, Intensive Care Unit Admission, and Intubation among Hospitalized Patients with COVID-19: A One-Year Retrospective Study in Jordan
    Al Oweidat, Khaled
    Al-Amer, Rasmieh
    Saleh, Mohammad Y.
    Albtoosh, Asma S.
    Toubasi, Ahmad A.
    Ribie, Mona Khaled
    Hasuneh, Manar M.
    Alfaqheri, Daniah L.
    Alshurafa, Abdullah H.
    Ribie, Mohammad
    Ali, Amira Mohammed
    Obeidat, Nathir
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (07)
  • [30] Effect of Corticosteroid Therapy on the Duration of SARS-CoV-2 Clearance in Patients with Mild COVID-19: A Retrospective Cohort Study
    Cheng Ding
    Xuewen Feng
    Yanfei Chen
    Jing Yuan
    Ping Yi
    Yongtao Li
    Qin Ni
    Rongrong Zou
    Xiaohe Li
    Jifang Sheng
    Lanjuan Li
    Kaijin Xu
    Infectious Diseases and Therapy, 2020, 9 : 943 - 952